NCT02702843

Brief Summary

The Study is designed to compare the effectiveness of Near Infrared Fluorescence Cholangiography (NIFC) to standard white light imaging (WLI) in visualizing and identifying the main biliary and hepatic structures (Cystic Duct, Right Hepatic Duct, Common Hepatic Duct, Common Bile Duct, Cystic-CBD junction, Cystic-Gallbladder junction and any Accessory Ducts) during laparoscopic cholecystectomy. The aim is to demonstrate that NIFC performs better than standard white light (WLI) alone in visualizing and identifying extra-hepatobiliary structures (Cystic Duct, Right Hepatic Duct, Common Hepatic Duct, Common Bile Duct, Cystic-CBD junction, Cystic-Gallbladder junction, and any Accessory Ducts) before and after dissection during Laparoscopic Cholecystectomy (LC).

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
677

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2016

Typical duration for not_applicable

Geographic Reach
5 countries

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 9, 2016

Completed
23 days until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2018

Completed
7.2 years until next milestone

Results Posted

Study results publicly available

November 12, 2025

Completed
Last Updated

November 12, 2025

Status Verified

October 1, 2025

Enrollment Period

1.8 years

First QC Date

February 17, 2016

Results QC Date

May 5, 2020

Last Update Submit

October 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Detection Rate of Common Bile Duct Before and After Dissection Using Near Infra-red Light

    Detection rate of the common bile duct during laparoscopic cholecystectomy, defined as the proportion of patients in whom the common bile duct was visualized immediately before dissection (baseline) and immediately after dissection using near infrared light. The detection rate was calculated separately for each arm and reported as the percentage of patients with successful identification.

    Immediately before dissection (baseline) and immediately after dissection during the same surgical procedure.

Study Arms (2)

Xenon Light

ACTIVE COMPARATOR

Laparoscopic cholecystectomy with Xenon Light

Procedure: Laparoscopic cholecystectomy with Xenon light

Near infrared light

EXPERIMENTAL

Laparoscopic cholecystectomy with Near infrared light

Procedure: Laparoscopic cholecystectomy with Xenon lightProcedure: Laparoscopic cholecystectomy (fluorescent cholangiography)

Interventions

Standard laparoscopic cholecystectomy with white light

Near infrared lightXenon Light

Laparoscopic cholecystectomy in infrared light after injection of indocyanine green pre-operatively.

Near infrared light

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of both genders
  • Minimum age: 18 years old
  • Spoken and written command of the language spoken in the country's center
  • Ability to understand and follow the study procedures and sign the informed consent

You may not qualify if:

  • Known allergies to iodides
  • Known history of coagulopathy
  • Known moderate or severe liver disease Women who are pregnant or breastfeeding, or for whom possibility of pregnancy was not ruled out

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Cedar Sinai

Los Angeles, California, 90048, United States

Location

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Hospital de clinicas jose de San Martin

Buenos Aires, Argentina

Location

Askelopios Westklinikum Hamburg

Hamburg, Germany

Location

Klinikum Sudstadt Rostock

Rostock, Germany

Location

University of Insubria

Varese, Italy

Location

University of Tokyo

Tokyo, Japan

Location

Related Publications (1)

  • Dip F, LoMenzo E, Sarotto L, Phillips E, Todeschini H, Nahmod M, Alle L, Schneider S, Kaja L, Boni L, Ferraina P, Carus T, Kokudo N, Ishizawa T, Walsh M, Simpfendorfer C, Mayank R, White K, Rosenthal RJ. Randomized Trial of Near-infrared Incisionless Fluorescent Cholangiography. Ann Surg. 2019 Dec;270(6):992-999. doi: 10.1097/SLA.0000000000003178.

MeSH Terms

Conditions

CholecystitisCholelithiasis

Interventions

Cholecystectomy, Laparoscopic

Condition Hierarchy (Ancestors)

Gallbladder DiseasesBiliary Tract DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

CholecystectomyBiliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, OperativeLaparoscopyEndoscopyMinimally Invasive Surgical Procedures

Results Point of Contact

Title
Lo Menzo, M.D.,Emanuele
Organization
Cleveland Clinic Florida

Study Officials

  • Raul Rosenthal, MD

    Cleveland Clinic Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 17, 2016

First Posted

March 9, 2016

Study Start

April 1, 2016

Primary Completion

December 31, 2017

Study Completion

August 31, 2018

Last Updated

November 12, 2025

Results First Posted

November 12, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Redcap will be used Data to be shared - pre-operative data including age, sex, laboratory values and imaging, intra-operative data including visualization of the extra-hepatic biliary structure with white light and with infrared light by the operating surgeon and the observer, any bile leak; post-operative data documenting any complications such as reaction to ICG or bile duct injury. Data will be available as each center finishes up the follow of each individual patient (usually 2 weeks post operatively). Each center will update the data on Redcap on a monthly basis. Data will be initially obtained on a pre-decided forms (approved by the IRB committee) and transferred to Redcap for electronic record keeping and analysis.

Locations